313 related articles for article (PubMed ID: 19895637)
1. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
Christiansen JS; Liebl A; Davidson JA; Ligthelm RJ; Halimi S
Diabetes Obes Metab; 2010 Feb; 12(2):105-14. PubMed ID: 19895637
[TBL] [Abstract][Full Text] [Related]
2. Premixed insulin treatment for type 2 diabetes: analogue or human?
Garber AJ; Ligthelm R; Christiansen JS; Liebl A
Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
[TBL] [Abstract][Full Text] [Related]
3. Insulin therapy in type 2 diabetes: what is the evidence?
van Avendonk MJ; Rutten GE
Diabetes Obes Metab; 2009 May; 11(5):415-32. PubMed ID: 19175375
[TBL] [Abstract][Full Text] [Related]
4. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study.
Fritsche A; Larbig M; Owens D; Häring HU;
Diabetes Obes Metab; 2010 Feb; 12(2):115-23. PubMed ID: 20092584
[TBL] [Abstract][Full Text] [Related]
5. Premixed insulin analogues for the treatment of diabetes mellitus.
Garber AJ
Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
[TBL] [Abstract][Full Text] [Related]
6. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
Rolla AR; Rakel RE
Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
[TBL] [Abstract][Full Text] [Related]
7. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
8. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
Mathur SK; Bansal A; Khan ZY
J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
[TBL] [Abstract][Full Text] [Related]
10. A review of human and analogue insulin trials.
Gough SC
Diabetes Res Clin Pract; 2007 Jul; 77(1):1-15. PubMed ID: 17112621
[TBL] [Abstract][Full Text] [Related]
11. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
Dashora U; Ashwell SG; Home PD
Diabetes Obes Metab; 2009 Jul; 11(7):680-7. PubMed ID: 19527481
[TBL] [Abstract][Full Text] [Related]
12. Designer insulins regimens in clinical practice--pilot multicenter Indian study.
Joshi SR; Kalra S; Badgandi M; Rao YS; Chawla M
J Assoc Physicians India; 2005 Sep; 53():775-9. PubMed ID: 16334621
[TBL] [Abstract][Full Text] [Related]
13. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations.
Evans M; Schumm-Draeger PM; Vora J; King AB
Diabetes Obes Metab; 2011 Aug; 13(8):677-84. PubMed ID: 21410860
[TBL] [Abstract][Full Text] [Related]
14. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
Ristic S; Bates PC
Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of the co-formulation of insulin degludec and insulin aspart.
Kumar A; Awata T; Bain SC; Ceriello A; Fulcher GR; Unnikrishnan AG; Arechavaleta R; Gonzalez-Gálvez G; Hirose T; Home PD; Kaku K; Litwak L; Madsbad S; Pinget M; Mehta R; Mithal A; Tambascia M; Tibaldi J; Christiansen JS
Int J Clin Pract; 2016 Aug; 70(8):657-67. PubMed ID: 27384031
[TBL] [Abstract][Full Text] [Related]
16. Insulin therapy for type 2 diabetes: premixed or basal-prandial?
Halbron M; Jacqueminet S; Sachon C; Bosquet F; Hartemann-Heurtier A; Grimaldi A
Diabetes Metab; 2007 Sep; 33(4):316-20. PubMed ID: 17466560
[TBL] [Abstract][Full Text] [Related]
17. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
18. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.
Lankisch MR; Ferlinz KC; Leahy JL; Scherbaum WA;
Diabetes Obes Metab; 2008 Dec; 10(12):1178-85. PubMed ID: 19040645
[TBL] [Abstract][Full Text] [Related]
19. Refining basal insulin therapy: what have we learned in the age of analogues?
Devries JH; Nattrass M; Pieber TR
Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
[TBL] [Abstract][Full Text] [Related]
20. Strategies for insulin therapy in type 2 diabetes.
Edelman SV; Morello CM
South Med J; 2005 Mar; 98(3):363-71. PubMed ID: 15813164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
